BioprintX, PAFIAST, Khanpur Road, Mang, Haripur (2026)

11/02/2026

Mr. Haseeb Ahmad
Chief Executive Officer & Co-Founder
BioprintX Pvt. Ltd.

Mr. Haseeb Ahmad is a distinguished biotech entrepreneur, technology strategist, and innovation leader serving as the Chief Executive Officer and Co-Founder of BioPrintX Pvt. Ltd. With advanced academic training in Bioinformatics and Biotechnology from Comsats University Islamabad, he brings a multidisciplinary perspective that integrates life sciences, data intelligence, and digital systems architecture to drive biotechnology commercialization and regenerative medicine innovation.

Over the course of his career, Mr. Haseeb has maintained strong affiliations with leading academic, governmental, and policy institutions. He serves as Executive Director of Jaamiah, an Higher Education Commission, Pakistan funded socio-entrepreneurial EdTech initiative incubated at COMSATS University Islamabad and endorsed by COMSTECH (OIC), where he has established strategic collaborations with institutions including the University of Bolton International, IDP Education Pakistan, Malala Fund, and Zindagi Trust. He has also served as Lecturer and Data Manager at the Health Services Academy, Islamabad, contributing to national-level PSDP-funded health human resource projects and introducing the Healthcare Data Analysis & Management (HDAM) certification program.

His professional engagements further include his tenure at the Pakistan Council for Science & Technology (PCST), where he contributed to major national initiatives such as the First Industrial Innovation Survey, the Need Assessment of Highly Qualified S&T Human Resource, the Research Productivity Award, and the Productive Scientists of Pakistan Index. He has supported policy development efforts including the National Startup Policy and Industry–Academia Linkage Framework. Additionally, he has served as a Grant Reviewer for the Higher Education Commission’s Technology Development Fund, a Member of the Expert Committee on Technology Foresight at PCST, an IEEE Young Professional Member, and was recognized as a Finalist for the Acumen Fellowship.

Technically proficient in data strategy, cloud systems, server administration, and large-scale dashboard development, Mr. Haseeb has led the design of national repositories, analytical platforms, and digital infrastructures supporting science, technology, and education sectors. At BioPrintX, he leads corporate strategy, digital innovation, commercialization planning, and institutional partnerships. His leadership is focused on transforming advanced biomaterials and regenerative medicine research into scalable, regulatory-aligned healthcare solutions, while strengthening Pakistan’s bioeconomy and innovation ecosystem through structured academia–industry collaboration.

11/02/2026

On the International Day of Women & Girls in Science, BioprintX proudly celebrates the remarkable women who are driving innovation, advancing research, and shaping the future of science every day.

We honor the passion, dedication, and contributions of women and girls who continue to break barriers, inspire change, and lead the way in scientific excellence. Your strength and curiosity are building a better tomorrow for generations to come.

Department of Biological & Health Sciences Directorate General of Science & Technology Government of Khyber Pakhtunkhwa Pak Austria Fachhochschule

07/02/2026

BioprintX (Pvt.) Ltd., under the esteemed leadership of Dr. Fazli Wahid (Fulbright Fellow | Associate Professor, Pak Austria Fachhochschule, Pride of Pakistan Government of Pakistan), proudly announces the successful achievement of multiple internationally recognized ISO certifications — a major milestone reflecting our commitment to excellence, innovation, and global standards.

✔ ISO 9001:2015 – Quality Management Systems
✔ ISO 14001:2015 – Environmental Management Systems
✔ ISO 13485:2016 – Medical Devices Quality Management Systems

These certifications strengthen BioPrintX’s foundation for developing advanced biomedical solutions while ensuring adherence to globally accepted practices in safety, quality, and sustainability. Recognized across more than 80 countries, including the United States and Europe, these standards will play a key role in supporting future regulatory approvals and facilitating global market access as BioPrintX moves toward commercial-scale production.

This achievement reflects the dedication, innovation, and collective efforts of our team in advancing healthcare technologies and positioning Pakistan on the global biotechnology map.

ACS Registrars Pakistan Government of Khyber Pakhtunkhwa Directorate General of Science & Technology Department of Biological & Health Sciences Chief Minister Khyber Pakhtunkhwa Muhammad Sohail Afridi

26/01/2026

BioprintX Private Limited recently welcomed the ISO audit team to its facility at Department of Biological & Health Sciences, Pak Austria Fachhochschule as part of the ongoing certification evaluation process. The visit included a comprehensive tour of our laboratories and facilities, detailed reviews of our products and workflows, and technical discussions with the BioPrintX team to assess our systems and operational readiness.

During the visit, Dr. Fazli Wahid, Fulbright Fellow (USA) and Founder of BioPrintX, formally presented the project, sharing the vision, research scope, and progress in bioprinting and medical technologies. The auditors engaged with the team and observed our development processes, documentation practices, and quality-driven culture.

BioPrintX is founded by Dr. Fazli Wahid and his research team and is being developed under a Directorate General of Science & Technology, Government of Khyber Pakhtunkhwa funded R&D project titled “Development of Artificial Skin & Tissue Substitutes Based on 3D Bio-Printed Advanced Materials.” The project is focused on translating advanced scientific research into safe, reliable, and medical-grade solutions for wound care and regenerative medicine.

Our growing product portfolio reflects this mission and includes:
Blanket of Hope – Next-Generation Emergency Wound Care
Ink for Life – Advanced Bioinks for Tissue Engineering
Precision Wound Dressing – Personalized Wound-Healing Patch
Smart Healing Drape – Universal Dressing for Everyday Healing
Next Generation Cosmetics – Regenerative Bioactive Skincare Line

This visit further strengthens BioPrintX’s regulatory journey and builds upon our existing compliance framework, including the formal site approval already granted by the Drug Regulatory Authority of Pakistan - DRAP for establishing a medical device manufacturing facility at Technology Park, PAF-IAST, Haripur.

Together, these developments highlight BioPrintX’s steady progress toward international standards, reflecting our dedication to quality, innovation, and delivering patient-centered biomedical solutions for the future.

24/01/2026

BioPrintX proudly announces the successful achievement of Drug Regulatory Authority of Pakistan - DRAP Site Approval for establishing a medical device manufacturing facility at the Technology Park, Pak Austria Fachhochschule, dedicated to the development of Next-Generation Advanced Wound Dressings and Artificial Skin Substitutes. This milestone marks a major step forward in our mission to transform innovative biomedical research into regulated, market-ready healthcare solutions for Pakistan.

This achievement has been made possible under the Directorate General of Science & Technology DGST-funded R&D project “Development of Artificial Skin & Tissue Substitutes Based on 3D Bio-Printed Advanced Materials”. We express our sincere gratitude to the Directorate General of Science & Technology (DGST), Government of Khyber Pakhtunkhwa, for their financial support, guidance, and trust in innovation-driven research.

BioPrintX is deeply thankful to PAF-IAST, its Administration, and the Department of Biological & Health Sciences for their continuous institutional support and for providing a strong research and innovation ecosystem. We also acknowledge the dedication of our research team and the visionary leadership of Dr. Fazli Wahid, whose commitment and expertise made this achievement possible. This approval is a significant step toward strengthening Pakistan’s medical device manufacturing capability and advancing indigenous healthcare innovation.

24/01/2026

🌟 Welcome on Board – Mr. Fauzan Ur Rahman | Clinical Research Coordinator

We are delighted to welcome Mr. Fauzan Ur Rahman to the BioprintX team as our Clinical Research Coordinator. With a strong academic background in Public Health and Nutrition and practical experience in disease surveillance, clinical data handling, and healthcare research, he brings valuable expertise to support our clinical and translational research activities. His role will be instrumental in ensuring accurate data management, ethical research practices, and smooth coordination between laboratory innovations and clinical applications.

Mr. Fauzan’s experience in case detection, disease reporting, biosafety practices, and community health programs strengthens BioPrintX’s capacity to validate and translate biomedical products into real-world healthcare solutions. His commitment to improving patient outcomes and advancing evidence-based research aligns perfectly with BioPrintX’s mission to develop innovative, reliable, and patient-centric regenerative technologies for Pakistan’s healthcare system.

23/01/2026

Pak Austria Fachhochschule: Institute of Applied Sciences and Technology (PAF-IAST) proudly announces a historic milestone in applied research and indigenous innovation. PAF-IAST has achieved formal site approval from the Drug Regulatory Authority of Pakistan - DRAP to establish a local medical device manufacturing facility at the Technology Park, PAF-IAST Haripur, dedicated to Next-Generation Advanced Wound Dressings and Artificial Skin Substitutes.

This achievement is part of the Directorate General of Science & Technology DGST-funded R&D project titled: “Development of Artificial Skin & Tissue Substitutes Based on 3D Bio-Printed Advanced Materials” (Project Code: DGST/BSTICE R&D-Cons/2024-2025/1332)

This landmark success reflects the exceptional commitment, dedication, and perseverance of Dr. Fazli Wahid and his research team, whose continuous efforts have transformed innovative research into a nationally recognized regulatory milestone.

Under the visionary leadership of Dr. Fazli Wahid—Fulbright Fellow, Associate Professor Department of Biological & Health Sciences at PAF-IAST, recipient of the Pride of Pakistan award, and an innovator with 15+ years of R&D experience in biomaterials, 3D bioprinting, and tissue engineering—this project sets new benchmarks for biomedical innovation. As Founder of BioprintX Pvt. Ltd. and Co-Founder of Radiant Aura, he continues to advance next-generation wound care and regenerative technologies in Pakistan.

Special appreciation is extended to the PAF-IAST Administration and Management for their unwavering support and strategic vision in strengthening industry–academia collaboration and promoting translational research.

This facility will be the first of its kind in Khyber Pakhtunkhwa, marking a historic step toward strengthening Pakistan’s medical device manufacturing ecosystem, accelerating research commercialization, and advancing healthcare innovation.

With the financial support and guidance of the Directorate General of Science & Technology (DGST), Government of Khyber Pakhtunkhwa.

17/01/2026

🌟 Advisory Board Spotlight – Dr. Taous Khan (PhD, Post-Doc)

We are honored to introduce Dr. Taous Khan, a distinguished scientist and a highly respected member of the Advisory Board of BioprintX Pvt. Ltd., whose expertise strengthens our mission to advance biomedical innovation, regenerative medicine, and translational biotechnology in Pakistan.

Dr. Taous Khan is currently a Professor at the Department of Pharmacy, COMSATS University Islamabad, Abbottabad Campus and brings with him an exceptional academic and research legacy. With two PhD degrees (Pharmacognosy and Biochemical Engineering), a Postdoctoral Fellowship from Kyungpook National University, South Korea, and decades of international research experience, he is among Pakistan’s most accomplished researchers in biomaterials, pharmacognosy, wound healing, and tissue regeneration.

His scientific impact is remarkable:
🔬 250+ research publications in high-impact international journals
📈 8,650+ citations on Google Scholar
🏆 h-index: 42 | i10-index: 110
📊 Total Impact Factor: 500+

Dr. Taous Khan is a pioneer in bacterial cellulose research, wound healing biomaterials, phytopharmacology, and green nanocomposites, with multiple national and international patents, including innovations in wound healing formulations and bacterial cellulose–based medical products. His work has directly shaped modern approaches to artificial skin, burn care, and regenerative wound dressings—the very foundation of BioPrintX’s innovation ecosystem.

He is also a visionary academic mentor who has supervised and co-supervised dozens of PhD and MS researchers, developing a strong pipeline of scientists now contributing globally in biomedical sciences, drug delivery, and biomaterial engineering.

As a Co-Principal Investigator of BioPrintX’s flagship Directorate General of Science & Technology DGST-funded project:
“Development of Artificial Skin and Tissue Substitutes Based on 3D Bio-Printed Advanced Materials,”
Dr. Taous Khan plays a critical advisory role in guiding scientific direction, material validation, and translational research strategy, ensuring that BioPrintX products meet the highest international scientific and clinical standards.

His presence on the BioPrintX Advisory Board reflects our commitment to:
✔ Scientific excellence
✔ Indigenous biomedical innovation
✔ Evidence-based product development
✔ Global research credibility

With his unparalleled experience, mentorship, and research leadership, Dr. Taous Khan continues to shape the future of regenerative medicine, biomaterials, and biotechnology in Pakistan and beyond.

🔗 Google Scholar: https://scholar.google.com/citations?user=WlgbAHkAAAAJ&hl=en
https://bioprintx.com/

07/01/2026

Meet our PhD scholar researchers, academically enrolled in the Department of Biological & Health Sciences at Pak Austria Fachhochschule and professionally engaged as senior researchers at BioprintX. They are contributing to a newly initiated Directorate General of Science & Technology DGST-funded research project titled “Development of Artificial Skin & Tissue Substitutes Based on 3D Bio-Printed Advanced Materials,”
Project ID: DGST/BSTICE R&D-Cons/2024-2025/1332
working under the leadership of Founder and Principal Investigator, Dr. Fazli Wahid, to advance innovation in regenerative medicine and biomedical research.

https://bioprintx.com

05/01/2026

🌟 TEAM SPOTLIGHT – Laiba Shah

Senior Researcher | Organoids & Tumoroids

Meet Laiba Shah, a Senior Researcher at BioprintX and PhD Scholar in Biotechnology, working at the intersection of precision oncology, organoid technology, and regenerative medicine.

Laiba is a core contributor to the Directorate General of Science & Technology flagship project
“Development of Artificial Skin and Tissue Substitutes Based on 3D Bio-Printed Advanced Materials” at Department of Biological & Health Sciences Pak Austria Fachhochschule (PAF-IAST). Her work focuses on developing living tissue models, including organoids and tumoroids, to advance personalized medicine, disease modeling, and translational biomedical research.

Laiba Biography for socials

With over three years of research experience in molecular biology and cancer biology, her previous work on Oral Squamous Cell Carcinoma (OSCC) explored novel diagnostic and prognostic biomarkers, strengthening her expertise in tissue handling, experimental design, and collaborative research. She has presented her research at leading international forums, including AACR, ISMB/ECCB, and Shaukat Khanum Cancer Symposiums.

🔬 Research Interests
• Organoids & Tumoroids
• Precision Oncology
• Diagnostic & Prognostic Biomarkers
• Regenerative & Translational Medicine

Driven by scientific curiosity and clinical impact, Laiba Shah represents the next generation of researchers transforming bioengineered medicine and personalized healthcare in Pakistan.

🔗 www.bioprintx.com

05/01/2026

TEAM SPOTLIGHT – Shazma Yousaf

Senior Researcher | 3D Bioprinting & Bio-Cellulose–Based Wound Dressings

Ms. Shazma Yousaf is a Senior Researcher at BioprintX Pvt. Ltd. and a Directorate General of Science & Technology DGST-funded PhD Scholar at Department of Biological & Health Sciences Pak Austria Fachhochschule whose work lies at the forefront of 3D bioprinting, artificial skin development, and regenerative wound-care technologies. With a strong academic background in Biotechnology (MS) and Zoology (BS), she represents a new generation of scientists translating laboratory innovation into clinically relevant biomedical solutions.

Currently, Ms. Shazma is actively contributing to the national flagship R&D initiative titled:
“Development of Artificial Skin and Tissue Substitutes Based on 3D Bio-Printed Advanced Materials.”
Her research directly supports Pakistan’s first indigenous efforts to develop bioprinted artificial skin constructs and bio-cellulose–based wound dressings for burn and trauma care.

Research Focus & Technical Contributions

Ms. Shazma’s work integrates biomaterial engineering, bioink design, and tissue engineering, with particular emphasis on:

Development and optimization of alginate-based and composite bioinks for artificial skin scaffolds

Bio-cellulose–based wound dressings for partial-thickness burns

Cell culture and scaffold–cell interactions to assess biocompatibility and regenerative potential

Application of advanced characterization techniques, including confocal microscopy, fluorescence microscopy, SEM, FTIR, and XRD

Hands-on expertise in electrospinning and 3D bioprinting software platforms

Her MS thesis at PAF-IAST (2023), “Analysis of Alginate-Based Bioink for the Designing of Artificial Skin,” laid the scientific foundation for her ongoing PhD research in bioprinted tissue substitutes.

Academic & Scholarly Contributions

Ms. Shazma has actively contributed to scientific dissemination through:

A peer-reviewed publication on miRNA-mediated protection against viral hepatitis

An international symposium presentation on Bio-cellulose-Based Potential Skin Grafts for Partial-Thickness Burns

Participation and facilitation in hands-on training courses on 3D bioprinting, including serving as a resource person in national workshops

Her academic excellence has been recognized through multiple distinctions, including:

1st Position – Zindigi Prize for the project “Bioinks” (2023)

Award for Hands-on Training in 3D Bioprinting (PAF-IAST, 2023)

1st Position in Poster & Research Competitions at national and university levels

Teaching, Training & Professional Engagement

Alongside her research role, Ms. Shazma has served as:

Lecturer & Teaching Assistant at PAF-IAST (2022–2024), teaching courses in Biotechnology, Tissue Engineering, Recombinant DNA Technology, and Cell & Molecular Biology

A contributor to training, demonstrations, and technical documentation at BioPrintX, supporting R&D prototyping, lab testing, and project exhibitions

Her multidisciplinary skill set spans laboratory management, scientific communication, digital media, and academic mentoring, making her a valuable contributor to both research and outreach activities.

Role at BioPrintX

At BioPrintX, Ms. Shazma plays a key role in:

Bioink formulation and biomaterial characterization

Laboratory testing of artificial skin and wound-care prototypes

Supporting documentation, reporting, and scientific content development

Training and demonstration sessions for students, collaborators, and visiting stakeholders

Vision

“To contribute to Pakistan’s biomedical research ecosystem by developing safe, affordable, and clinically effective bioprinted tissue substitutes that improve patient healing and healthcare outcomes.”

Driven by scientific curiosity, creativity, and a strong sense of purpose, Ms. Shazma Yousaf continues to advance BioPrintX’s mission of indigenous biomedical innovation, medical self-reliance, and next-generation regenerative healthcare solutions for Pakistan.

https://bioprintx.com

03/01/2026

🌟 Team Spotlight – Saba Iftikhar | Senior Researcher (3D Bioprinting & Bio-Cellulose Wound Dressings)

We are pleased to highlight Saba Iftikhar, a Senior Researcher at BioPrintX and PhD Scholar in Biotechnology Department of Biological & Health Sciences Pak Austria Fachhochschule , contributing to Pakistan’s advancing capabilities in artificial skin, 3D bioprinting, and bio-cellulose–based wound healing technologies.

Saba is an active Research Associate on the Directorate General of Science & Technology DGST-funded flagship project, “Development of Artificial Skin Tissue Substitutes Based on 3D Bioprinted Advanced Materials.” Her work integrates biomaterial engineering, bio-ink formulation, and natural extract–based therapeutics to develop affordable, effective, and clinically relevant wound-healing solutions.

With expertise in 3D bioprinting, tissue engineering, and regenerative medicine, her research focuses on designing bioengineered tissues and advanced wound dressings, including bio-cellulose–based systems, aimed at improving healing outcomes for burn and trauma patients. Her approach bridges cutting-edge bioprinting technologies with translational research, supporting the development of scalable biomedical products.

Saba has also contributed to peer-reviewed scientific literature, including a comprehensive review on miRNA-mediated protection against viral hepatitis published in the European Journal of Microbiology & Infectious Diseases. Alongside her research role, she has served as a Teaching Assistant at PAF-IAST and previously worked as a Research Analyst at Radiant Aura, gaining valuable experience in applied research and product development.

Driven by a strong commitment to local biomedical manufacturing and innovation, Saba Iftikhar represents the emerging generation of researchers at BioPrintX working to transform scientific discoveries into real-world regenerative healthcare solutions for Pakistan.

🔗 www.bioprintx.com

BioprintX

11/02/2026

11/02/2026

07/02/2026

26/01/2026

24/01/2026

24/01/2026

23/01/2026

17/01/2026

07/01/2026

05/01/2026

05/01/2026

03/01/2026

Address

Website

Alerts

Shortcuts

Share

Category